Assignee
INTERCELL AG
AT·25 granted patents·23 pending applications·396 citations·filing 1999–2013
Top patents by PatentIndex Score
48 records- 0192US8372411B2S. pneumoniae antigensINTERCELL AG·Filed 2009·Granted Feb 12, 2013·19 cites·30 claims
- 0292US7485710B2Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereofINTERCELL AG·Filed 2003·Granted Feb 3, 2009·43 cites·1 claims
- 0392US7438912B2S.agalactiae antigens I + IIINTERCELL AG·Filed 2004·Granted Oct 21, 2008·46 cites·7 claims
- 0492US7148191B2Antigenic compositionINTERCELL AG·Filed 2001·Granted Dec 12, 2006·58 cites·22 claims
- 0591US7635487B2S. pneumoniae antigensINTERCELL AG·Filed 2004·Granted Dec 22, 2009·29 cites·16 claims
- 0691US6869607B1Vaccine formulationsINTERCELL AG·Filed 1999·Granted Mar 22, 2005·110 cites·28 claims
- 0789US7771728B2Method for identification, isolation and production of antigens to a specific pathogenINTERCELL AG·Filed 2006·Granted Aug 10, 2010·10 cites·13 claims
- 0887US7658928B2Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptideINTERCELL AG·Filed 2007·Granted Feb 9, 2010·6 cites·6 claims
- 0984US7960533B2Nucleic acids coding for adhesion factor of group B Streptococcus, adhesion factors of group B Streptococcus and further uses thereofINTERCELL AG·Filed 2009·Granted Jun 14, 2011·5 cites·16 claims
- 1083US7927607B2S. agalactiae antigens I and IIINTERCELL AG·Filed 2008·Granted Apr 19, 2011·5 cites·10 claims
- 1182US7704514B2VaccinesINTERCELL AG·Filed 2004·Granted Apr 27, 2010·14 cites·9 claims
- 1282US7244438B2Uses for polycationic compoundsINTERCELL AG·Filed 2002·Granted Jul 17, 2007·11 cites·4 claims
- 1377US7638136B2Streptococcus pyogene antigensINTERCELL AG·Filed 2004·Granted Dec 29, 2009·10 cites·16 claims
- 1476US8343510B2Protective proteins of S. agalactiae, combinations thereof and methods of using the sameINTERCELL AG·Filed 2008·Granted Jan 1, 2013·1 cites·15 claims
- 1575US7378234B2Method for isolating hepatitis C virus peptidesINTERCELL AG·Filed 2003·Granted May 27, 2008·11 cites·31 claims
- 1674US7968297B2Method for identification, isolation and production of antigens to a specific pathogenINTERCELL AG·Filed 2002·Granted Jun 28, 2011·7 cites·16 claims
- 1772US7528223B2Antigens encoded by alternative reading frames from pathogenic virusesINTERCELL AG·Filed 2003·Granted May 5, 2009·6 cites·41 claims
- 1870US8361476B2Vaccine composition comprising an antigen and a peptide having adjuvant propertiesINTERCELL AG·Filed 2001·Granted Jan 29, 2013·4 cites·5 claims
- 1968US7628994B2S. epidermidis antigensINTERCELL AG·Filed 2004·Granted Dec 8, 2009·1 cites·9 claims
- 2065US8349336B2Streptococcus pyogenes antigensINTERCELL AG·Filed 2009·Granted Jan 8, 2013·0 cites·15 claims
- 2163US8945591B2Methods and compositions involving immunostimulatory oligodeoxynucleotidesINTERCELL AG·Filed 2013·Granted Feb 3, 2015·0 cites·14 claims
- 2263US2007218073A1Antigenic compositionINTERCELL AG·Filed 2006·Application pending·0 cites
- 2362US7538083B2Compositions and methods for the potentiation of immune responses against target antigensINTERCELL AG·Filed 2004·Granted May 26, 2009·0 cites·17 claims
- 2462US2011236414A1Bacterial Polysaccharide-Polypeptide Conjugate CompositionsINTERCELL AG·Filed 2009·Application pending·0 cites
- 2562US2013122030A1S. epidermidis antigensINTERCELL AG·Filed 2013·Application pending·0 cites
- 2658US2006240029A1Chlamydia pneumoniae antigensINTERCELL AG·Filed 2004·Application pending·0 cites
- 2757US8372410B2S. epidermidis antigensINTERCELL AG·Filed 2012·Granted Feb 12, 2013·0 cites·14 claims
- 2857US2008175856A1Enterococcus AntigensINTERCELL AG·Filed 2004·Application pending·0 cites
- 2955US2009060875A1HCV Vaccines for Chronic HCV PatientsINTERCELL AG·Filed 2005·Application pending·0 cites
- 3053US2013216583A1Vaccine composition comprising an antigen and a peptide having adjuvant propertiesINTERCELL AG·Filed 2013·Application pending·0 cites
- 3153US2013136761A1S. pneumoniae antigensINTERCELL AG·Filed 2013·Application pending·0 cites
- 3253US2013122047A1Streptococcus pyogenes antigensINTERCELL AG·Filed 2012·Application pending·0 cites
- 3353US2007041998A1Use of alum and a th1 immune response inducing adjuvant for enhancing immune responsesINTERCELL AG·Filed 2004·Application pending·0 cites
- 3453US2007031446A1Hcv vaccinesINTERCELL AG·Filed 2004·Application pending·0 cites
- 3551US2013109845A1Fully human influenza m2 specific antibodiesINTERCELL AG·Filed 2012·Application pending·0 cites
- 3651US2013116406A1Borrelia antigensINTERCELL AG·Filed 2012·Application pending·0 cites
- 3750US2013280288A1Peptides protective against s. pneumoniae and compositions, methods and uses relating theretoINTERCELL AG·Filed 2013·Application pending·0 cites
- 3849US8795690B2Protective proteins of S. agalactiae, combinations thereof and methods of using the sameINTERCELL AG·Filed 2012·Granted Aug 5, 2014·0 cites·12 claims
- 3948US2010203075A1Chlamydia antigensINTERCELL AG·Filed 2008·Application pending·0 cites
- 4045US2006193866A1H pylori antigensINTERCELL AG·Filed 2004·Application pending·0 cites
- 4143US2005220788A1Use of molecules which interact with the haptoglobin receptor ligand bindingINTERCELL AG·Filed 2003·Application pending·0 cites
- 4243US2009186047A1HCV VaccinationsINTERCELL AG·Filed 2006·Application pending·0 cites
- 4342US7858588B2Immunostimulatory oligodeoxynucleic moleculesINTERCELL AG·Filed 2002·Granted Dec 28, 2010·0 cites·26 claims
- 4442US2008145383A1Method for Solubilizing Peptide MixturesINTERCELL AG·Filed 2005·Application pending·0 cites
- 4541US2013266575A1OprF/I AGENTS AND USE THEREOF IN HOSPITALIZED AND OTHER PATIENTSINTERCELL AG·Filed 2013·Application pending·0 cites
- 4641US2010047263A1Peptides protective against s. pneumoniae and compositions, methods and uses relating theretoINTERCELL AG·Filed 2007·Application pending·0 cites
- 4739US2007128183A1Td antigensINTERCELL AG·Filed 2005·Application pending·0 cites
- 4838US2005250716A1Immunostimulatory oligodeoxynucleotidesINTERCELL AG·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INTERCELL AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →